
Praxis Precision Medicines: Essential3 Update and Corporate News – A Look Into Their Latest Developments
Praxis Precision Medicines: A New Breakthrough in Central Nervous System Disorders Boston, MA – February 28, 2025 – Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a pioneering biopharmaceutical company, recently provided an update on their clinical-stage research focused on translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal…